Resources

Despite the ubiquity of aluminum adjuvants, they often present development, manufacturing, and quality challenges to manufacturers. As more and more manufacturers work toward World Health Organization prequalification, insights from a manufacturing, quality, analytical, and characterization perspective would be of high value. This PATH-organized webinar features speakers who are experts in the field, and covers:Chemistry and immunobiology of aluminum adjuvantsGood manufacturing practices for producing aluminum-based vaccine adjuvantsApproaches for modulating immune response qualityAdvancements in alum+ adjuvantsLessons learned with aluminum adjuvantsSpeakers include:Lakshmi Khandke, Sr. Program Advisor, Vaccines, CMC, Center for Vaccine Innovation and Access, PATHHarm HogenEsch, Professor of Immunology, Purdue UniversityLaurent Duroux, Lead Scientist, R&D, Vaccine Adjuvant Systems, CRODA PharmaRajesh Gupta, Principal Consultant, Biologics Quality & Regulatory Consultants LLCRobert Sitrin, Senior Scientist, Center for Vaccine Innovation and Access, PATHChristopher Fox, Senior Vice President of Formulations, Access to Advanced Health InstituteDerek O'Hagan, Senior Advisor, Vaccines R&D, GSK

As one of the earliest and largest investors in Gavi, the Vaccine Alliance, the United States government (USG) is a critical partner in Gavi's mission to increase access to lifesaving vaccines. PATH is working closely with our partners to advocate for increased investment from the USG, ahead of Gavi's next replenishment cycle for 2026-2030. We designed this community factsheet on Gavi's impact for use by advocates to support their engagements with Congress.

For two decades, PATH has leveraged deep and diverse partnerships, evidence-based technical expertise, and a unique ability to drive crosscutting health solutions to advance health equity in Zambia.Working in collaboration with the government of Zambia, PATH helps develop, support, and scale up innovative approaches and technologies to address the country’s most pressing health priorities, improving public health and saving lives.In celebration of our partnership, we have compiled a compendium of successes celebrating two decades of impactful partnership between PATH and the Ministry of Health in Zambia.

For two decades, PATH has leveraged deep and diverse partnerships, evidence-based technical expertise, and a unique ability to drive crosscutting health solutions to advance health equity in Zambia.Working in collaboration with the government of Zambia, PATH helps develop, support, and scale up innovative approaches and technologies to address the country’s most pressing health priorities, improving public health and saving lives.In celebration of our partnership, we have compiled a compendium of research abstracts celebrating two decades of impactful partnership between PATH and the Ministry of Health in Zambia.

Since 2015, PATH has supported the Ministry of Health (MOH) in Uganda to develop and implement policies to help advance the health of women and children, including a five-year Reproductive, Maternal, Newborn, and Child, and Adolescent Health (RMNCAH) Sharpened Plan, which guided programming from 2016 to 2020. The plan expired as Uganda was recovering from the acute phase of the COVID-19 pandemic. PATH advocates jumped in to support the MOH in updating the plan and ensuring it reflected the changing health environment, and included a strong investment case to accelerate progress toward achievement of RMNCAH targets and universal health coverage.